Interestingly, a recent in vivo study on the anti-influenza activity of andrographolide in post-infection treatment revealed that andrographolide improved the survival rate and lung pathology, as well as demonstrating decreased viral loads and the expression of inflammatory cytokines via NF-kB and the JAK-STAT signaling pathway [144]. Here, NFKB1 is linked to influenza.